Evidence map›Paper›PMID 35486098›Full record

ArticleeLife2022

VE-cadherin enables trophoblast endovascular invasion and spiral artery remodeling during placental development.

Derek C Sung, Xiaowen Chen, Mei Chen, Jisheng Yang, Susan Schultz, Apoorva Babu, Yitian Xu, Siqi Gao, T C Stevenson Keller, Patricia Mericko-Ishizuka and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. mScience China. Life sciences · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Preeclampsia in the Context of COVID-19: Mechanisms, Pathophysiology, and Clinical Outcomes.American journal of reproductive immunology (New York, N.Y. : 1989) · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Derek C SungCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0001-6966-2596
Xiaowen ChenCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Mei ChenCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Jisheng YangCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Susan SchultzDepartment of Radiology, Hospital of the University of Pennsylvania, Philadelphia, United States.
Apoorva BabuCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Yitian XuCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Siqi GaoCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
T C Stevenson KellerCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Patricia Mericko-IshizukaCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.
Michelle LeeUniversity Laboratory Animal Resources, University of Pennsylvania, Philadelphia, United States.
Ying YangDepartment of Molecular Pharmacology and Physiology, University of South Florida, Tampa, United States.
Joshua P ScallanDepartment of Molecular Pharmacology and Physiology, University of South Florida, Tampa, United States.
Mark L KahnCardiovascular Institute, Department of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0002-6489-7086
Cardiovascular Institute of the South · USUniversity of South Florida · USHospital of the University of Pennsylvania · USUniversity of Pennsylvania · US

Funding

HEMATOLOGY CLINICAL RESEARCH TRAINING PROGRAMT32HL007439 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE F BRASS, PETER S KLEIN · 1985 to 2026
$17.1M
TRAINING GRANT IN HEMOSTASIS AND THROMBOSIST32HL007971 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Rodney M Camire · 2001 to 2026
$10.6M
MEKK3 signaling in hemogenic endotheliumR01HL142976 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAHN, MARK L · 2018 to 2021
$3.2M
Reciprocal VEGFC/VEGFR3-CDH5 regulation of lymphatic and sinusoidal vascular growthR01HL162795 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAHN, MARK L · 2022 to 2025
$2.4M
Pathways Regulating Lymphatic Vessel Permeability and Valve FormationR01HL142905 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI SCALLAN, JOSHUA PAUL · 2019 to 2023
$2.2M
Molecular mechanisms enhancing lymphatic valve formationR01HL145397 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI YANG, YING · 2019 to 2023
$1.9M
VEGF-C/VEGFR3 Regulation of VE-Cadherin in Sinusoidal Angiogenesis and LymphangiogenesisF30HL158014 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SUNG, DEREK C · 2021 to 2022
$85k
NHLBI NIH HHS F30 HL158014NHLBI NIH HHS R01 HL142905NHLBI NIH HHS R01 HL142976NHLBI NIH HHS R01 HL145397NHLBI NIH HHS R01 HL162795NHLBI NIH HHS T32 HL007439NHLBI NIH HHS T32 HL007971NIH HHS T32 HL007439NIH HHS T32 HL007971
6 · The paper itself

Abstract

During formation of the mammalian placenta, trophoblasts invade the maternal decidua and remodel spiral arteries to bring maternal blood into the placenta. This process, known as endovascular invasion, is thought to involve the adoption of functional characteristics of vascular endothelial cells (ECs) by trophoblasts. The genetic and molecular basis of endovascular invasion remains poorly defined, however, and whether trophoblasts utilize specialized endothelial proteins in an analogous manner to create vascular channels remains untested. Vascular endothelial (VE-)cadherin is a homotypic adhesion protein that is expressed selectively by ECs in which it enables formation of tight vessels and regulation of EC junctions. VE-cadherin is also expressed in invasive trophoblasts and is a prime candidate for a molecular mechanism of endovascular invasion by those cells. Here, we show that VE-cadherin is required for trophoblast migration and endovascular invasion into the maternal decidua in the mouse. VE-cadherin deficiency results in loss of spiral artery remodeling that leads to decreased flow of maternal blood into the placenta, fetal growth restriction, and death. These studies identify a non-endothelial role for VE-cadherin in trophoblasts during placental development and suggest that endothelial proteins may play functionally unique roles in trophoblasts that do not simply mimic those in ECs.

Indexed as

PlacentationTrophoblastsAnimalsAntigens, CDArteriesCadherin 5CadherinsDeciduaEndothelial CellsFemaleMammalsMicePlacentaPregnancyAntigens, CDCadherin 5Cadherinsdevelopmental biologymedicinemouseplacentaspiral arterytrophoblastVE-cadherin

Identifiers

PMID35486098
PMCPMC9106330
OpenAlexW4225116137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.